← Back to Clinical Trials
Recruiting NCT01694940
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Trial Parameters
Condition Mitochondrial Disorders
Sponsor Columbia University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2011-01-31
Completion 2026-12-31
Brief Summary
The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with or suspected to have a mitochondrial disorder * Adult carriers of known mitochondrial DNA mutations * Patients with laboratory analysis indicative of a mitochondrial disorder. * Medical information and tissue samples are also accepted from deceased individuals who fulfill the above criteria. Exclusion Criteria: * Patients not suspected of having a mitochondrial disorder * Patients not suspected of carrying a mitochondrial DNA or nuclear DNA mutation that affects mitochondrial function.